- Home
- BKSY vs ACRS Comparison
BKSY vs ACRS Comparison
Compare BKSY & ACRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKSY
- ACRS
- Stock Information
- Founded
- BKSY 2013
- ACRS 2012
- Country
- BKSY United States
- ACRS United States
- Employees
- BKSY N/A
- ACRS N/A
- Industry
- BKSY Radio And Television Broadcasting And Communications Equipment
- ACRS Biotechnology: Pharmaceutical Preparations
- Sector
- BKSY Technology
- ACRS Health Care
- Exchange
- BKSY Nasdaq
- ACRS Nasdaq
- Market Cap
- BKSY 157.7M
- ACRS 165.7M
- IPO Year
- BKSY N/A
- ACRS 2015
- Fundamental
- Price
- BKSY $22.88
- ACRS $1.63
- Analyst Decision
- BKSY Strong Buy
- ACRS Strong Buy
- Analyst Count
- BKSY 6
- ACRS 9
- Target Price
- BKSY $24.33
- ACRS $9.25
- AVG Volume (30 Days)
- BKSY 2.9M
- ACRS 1.3M
- Earning Date
- BKSY 08-07-2025
- ACRS 08-06-2025
- Dividend Yield
- BKSY N/A
- ACRS N/A
- EPS Growth
- BKSY N/A
- ACRS N/A
- EPS
- BKSY N/A
- ACRS N/A
- Revenue
- BKSY $107,401,000.00
- ACRS $17,777,000.00
- Revenue This Year
- BKSY $31.81
- ACRS N/A
- Revenue Next Year
- BKSY $27.70
- ACRS $8.11
- P/E Ratio
- BKSY N/A
- ACRS N/A
- Revenue Growth
- BKSY 7.05
- ACRS N/A
- 52 Week Low
- BKSY $3.86
- ACRS $1.05
- 52 Week High
- BKSY $28.85
- ACRS $5.17
- Technical
- Relative Strength Index (RSI)
- BKSY 61.38
- ACRS 58.55
- Support Level
- BKSY $21.10
- ACRS $1.51
- Resistance Level
- BKSY $28.85
- ACRS $1.63
- Average True Range (ATR)
- BKSY 1.98
- ACRS 0.08
- MACD
- BKSY 0.20
- ACRS 0.01
- Stochastic Oscillator
- BKSY 46.17
- ACRS 71.91
About BKSY BlackSky Technology Inc.
BlackSky Technology Inc is a provider of real-time geospatial intelligence. The company delivers on-demand, high-frequency imagery, monitoring, and analytics of some of the critical and strategic locations, economic assets, and events in the world. It designs, owns, and operates one of the industry's low earth orbit (LEO) small satellite constellations, optimized to capture imagery cost-efficiently where and when its customers need it. its Spectra AI software platform processes data from BlackSky's constellation and from other third-party sensors to develop the critical insights and analytics that provide its customers with the actionable intelligence. Geographically, the company operates in North America, the Middle East, Asia, and Others.
About ACRS Aclaris Therapeutics Inc.
Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two reportable segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing inventive therapies to address unmet needs for immuno-inflammatory diseases, and the contract research segment is engaged in providing laboratory services. A majority of the company's revenue is derived from the therapeutics segment. The various drug candidates in its product pipeline are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138, an ITJ Inhibitor; Bosakitug, ATI-052, and Lepzacitinib.